Nonspecific inflammation and structural changes in the arteries of hypertensive males at high and moderate risk for cardiovascular events
- Authors: Dmitriev VA1, Oshchepkova EV1, Titov VN1, Balakhonova TV1, Tripoten' MI1, Rogoza AN1, Shiriaeva I.K1
-
Affiliations:
- НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ "Российский научно-производственный комплекс" Минздравсоцразвития России, Москва
- Issue: Vol 84, No 9 (2012)
- Pages: 53-57
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31106
- ID: 31106
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
V A Dmitriev
НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ "Российский научно-производственный комплекс" Минздравсоцразвития России, Москва
E V Oshchepkova
НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ "Российский научно-производственный комплекс" Минздравсоцразвития России, Москва
V N Titov
НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ "Российский научно-производственный комплекс" Минздравсоцразвития России, Москва
T V Balakhonova
НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ "Российский научно-производственный комплекс" Минздравсоцразвития России, Москва
M I Tripoten'
НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ "Российский научно-производственный комплекс" Минздравсоцразвития России, Москва
A N Rogoza
НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ "Российский научно-производственный комплекс" Минздравсоцразвития России, Москва
Iu K Shiriaeva
НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ "Российский научно-производственный комплекс" Минздравсоцразвития России, Москва
References
- Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed. 2007.
- Levick J.R. An introduction to cardiovascular physiology. 5th ed. Horder Arnold 2010; 11.
- Ланг Г.Ф. Гипертоническая болезнь. М: Медгиз 1950: 7.
- Kaplan N.M. Clinical Hypertension. 9th ed. Lippincott Williams & Wilkins. 2006: 86.
- Wassmann S., Wassmann K., Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 2004; 44: 381-386.
- Lingyun W., Bernhard H., Juurlink J. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 2002; 39: 809-814.
- Oya T., Hattori N., Mizuno Y. et al. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem 1999; 274 (26): 18 492-18 502.
- Yamavaki H., Saito K., Okada M. et al. Methylglyoxal mediates vascular inflammation via JNK 38 in human endothelial cells. Am J Physiol Cell Physiol 2008; 295: 1510-1517.
- Chang T., Wu L. Methylglyoxal, oxidative stress, and hypertension. Can J Physiol Pharmacol 2006; 84: 1229-1238.
- Straczek C., Ducimetiere P., Barberger-Gateau P. et al. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study. J Am Geriatr Soc 2010; 58 (1): 129-135.
- Packard R.R.S., Libby P. Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clin Chem 2008; 54: 24-38.
- Koenig W., Khuseyinova N., Baumert J. et al. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women. Results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Arterioscl, Thrombos, Vasc Biol 2006; 26: 2745.
- Wang T.J., Gona P., Larson M.G. et al. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49 (3): 432-438.
- Mitchell G.F. Arterial stiffness and wave reflection: biomarkers of cardiovascular risk. Artery Res 2009; 3 (2): 56-64.
- Laurent S., Cockroft J., Van Bortel L. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.
- Laurent S., Boutouyrie P. Recent advances in arterial stiffness and wave reflections in human hypertension. Hypertension 2007; 49: 1202-1206.
- Laurent S., Boutouyrie P. Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol 2007; 20 (Suppl 12): 45-50.
- Andoh N., Minami J., Ishimitsu T. et al. Relationship between markers of inflammation and brachial-ankle pulse wave velocity in japanese men. Intern Heart J 2006; 47 (3): 409-420.
- Tsioufis C., Dimitriadis K., Selima M. et al. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J 2007; 28: 1162-1169.
- Amer M.S., Elawam A.E., Khater M.S. et al. Association of high-sensitivity C-reactive protein with carotid artery intima-media thickness in hypertensive older adults. J Am Soc Hypertens 2011; 5 (5): 395-400.
- Дмитриев В.А., Ощепкова Е.В., Титов В.Н. и др. С-реактивный белок и интерлейкин-6 при поражении органов-мишеней на ранних стадиях у больных гипертонической болезнью. Кардиол вестн 2007; 2: 55-61.
- Национальные рекомендации по диагностике и лечению артериальной гипертензии. ВНОК 2010 г., 4-й пересмотр. Доступно на http://www.scardio.ru/recommendations/approved00100/default.asp
- Pearson T.A., Mensah G.A., Wayne A.R. et al. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
- Чазова И.Е., Ощепкова Е.В., Чихладзе Н.М. Артериальная гипертония. Принципы диагностики и лечения (пособие для врачей). М 2005: 35.
- Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: stablishing normal and reference values. The Reference Values for Arterial Stiffness' Collaboration. Eur Heart J 2010; 31: 2338-2350.
- Wang X., Desai K., Chang T., Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J Hypertens 2005; 23: 1565-1573.
- Vasdev S., Cill V., Singal P.K. Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms. Vasc Health Risk Manag 2006; 2 (3): 263-276.
- Wu L. Is methylglyoxal causative factor for hypertension development? Can J Physiol Pharmacol 2006; 84: 129-139.
- Guan H., Wang P., Hui R. et al. Adeno-associated virus-mediated human C-reactive protein gene delivery causes endothelial dysfunction and hypertension in rats. Clin Chem 2009; 55 (2): 274-284.
- Титов В.Н., Осипов С.Г. Атеросклероз. Роль эндогенного воспаления, белков острой фазы и жирных кислот. М 2003; 279.